Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case–control study and a meta-analysis

[1]  S. Kuhara,et al.  Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells , 2017, Cytotechnology.

[2]  S. Koca,et al.  The IL-33 gene is related to increased susceptibility to systemic sclerosis , 2016, Rheumatology International.

[3]  M. Mahmoudi,et al.  IL‐1A rs1800587, IL‐1B rs1143634 and IL‐1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis , 2015, International journal of immunogenetics.

[4]  S. Mumtaz,et al.  Gene-gene, gene-environment, gene-nutrient interactions and single nucleotide polymorphisms of inflammatory cytokines. , 2015, World journal of diabetes.

[5]  R. Soares,et al.  Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis. , 2015, Autoimmunity reviews.

[6]  E. Hsieh,et al.  Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China. , 2014, Clinical and experimental rheumatology.

[7]  F. Carvalho,et al.  Interleukin-1β genotype and circulating levels in cancer patients: metastatic status and pain perception. , 2014, Clinical biochemistry.

[8]  M. Behmanesh,et al.  The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients , 2014, Journal of the Neurological Sciences.

[9]  Jing Wang,et al.  Association of Interleukin 1 Family with Systemic Sclerosis , 2014, Inflammation.

[10]  S. Sedimbi,et al.  IL-18 in inflammatory and autoimmune disease , 2013, Cellular and Molecular Life Sciences.

[11]  E. List,et al.  Multiple sclerosis: association with the interleukin-1 gene family polymorphisms in the Turkish population , 2013, The International journal of neuroscience.

[12]  T. Gambichler,et al.  Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis , 2012, Annals of the rheumatic diseases.

[13]  O. Melander,et al.  Genetic Variation Within the Interleukin-1 Gene Cluster and Ischemic Stroke , 2012, Stroke.

[14]  Jing Wang,et al.  Association of Interleukin 1α Promoter Polymorphism (–889C/T) with Susceptibility to Systemic Sclerosis , 2012, The Journal of Rheumatology.

[15]  Y. Lee,et al.  The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. , 2012, Joint, bone, spine : revue du rhumatisme.

[16]  J. Um,et al.  Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice , 2011, PloS one.

[17]  M. Coenen,et al.  Genetics of Systemic Sclerosis: An Update , 2011, Current Rheumatology Reports.

[18]  M. Conforti,et al.  Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement , 2011, Annals of the rheumatic diseases.

[19]  David M. Evans,et al.  A Comprehensive Evaluation of Potential Lung Function Associated Genes in the SpiroMeta General Population Sample , 2011, PloS one.

[20]  M. E. El behery,et al.  Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C–511T polymorphism with cervical cancer risk in Egyptian women , 2011, Molecular and Cellular Biochemistry.

[21]  K. Yanaba,et al.  Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis , 2011, Clinical Rheumatology.

[22]  G. Ning,et al.  association of interleukin-1 and interleukin-1 polymorphisms with the isk of Graves ’ disease in a case-control study and meta-analysis , 2022 .

[23]  Casey S Greene,et al.  Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. , 2008, Arthritis and rheumatism.

[24]  R. Scorza,et al.  Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. , 2007, Human immunology.

[25]  A. Scarpa,et al.  Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. , 2007, The Journal of rheumatology.

[26]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[27]  R. D. du Bois,et al.  Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. , 2004, The Journal of rheumatology.

[28]  N. Kamatani,et al.  Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. , 2003, Arthritis and rheumatism.

[29]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism , 1995 .